Clinical Trials Browser

Phase 2/3 × INDUSTRY × vinflunine × Clear all

NCT00389155 2015-12-07

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Phase 2/3 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT00359476 2010-03-02

A Study of Vinflunine in Patients With Gastric Cancer

Phase 2/3 Terminated

Gastrointestinal

Stomach Neoplasms